SAM
RCUS icon

Sectoral Asset Management’s Arcus Biosciences RCUS Stock Holding History

Sectoral Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Buy
110,870
+65,800
+146% +$1.63M 2.39% 10
2026
Q1 		$1.04M Sell
45,070
-11,875
-21% -$256K 0.86% 29
2025
Q4 		$1.36M Sell
56,945
-311,125
-85% -$6.35M 1.09% 28
2025
Q3 		$5.01M Buy
368,070
+110,800
+43% +$1.15M 3.09% 6
2025
Q2 		$2.09M Buy
257,270
+230,400
+857% +$1.97M 1.38% 18
2025
Q1 		$211K Sell
26,870
-42,682
-61% -$495K 0.16% 70
2024
Q4 		$1.04M Sell
69,552
-5,970
-8% -$97.5K 0.69% 40
2024
Q3 		$1.15M Sell
75,522
-2,863
-4% -$45.1K 0.68% 46
2024
Q2 		$1.19M Sell
78,385
-15,250
-16% -$246K 0.49% 53
2024
Q1 		$1.77M Sell
93,635
-3,800
-4% -$65.7K 0.7% 46
2023
Q4 		$1.86M Sell
97,435
-278,021
-74% -$4.44M 0.8% 50
2023
Q3 		$6.74M Buy
375,456
+20,966
+6% +$421K 1.31% 26
2023
Q2 		$7.2M Buy
354,490
+60,844
+21% +$1.16M 1.2% 33
2023
Q1 		$5.36M Buy
293,646
+55,164
+23% +$1.05M 1.03% 41
2022
Q4 		$4.93M Buy
238,482
+11,450
+5% +$315K 0.95% 47
2022
Q3 		$5.94M Sell
227,032
-84,750
-27% -$2.24M 1.17% 32
2022
Q2 		$7.9M Sell
311,782
-26,698
-8% -$654K 1.59% 20
2022
Q1 		$10.7M Buy
338,480
+55,270
+20% +$1.85M 1.9% 15
2021
Q4 		$11.5M Sell
283,210
-455,800
-62% -$17.7M 1.73% 17
2021
Q3 		$25.8M Buy
739,010
+64,750
+10% +$2.02M 2.14% 4
2021
Q2 		$18.5M Sell
674,260
-184,950
-22% -$5.28M 1.5% 23
2021
Q1 		$24.1M Sell
859,210
-1,950
-0.2% -$67.9K 1.83% 14
2020
Q4 		$22.4M Sell
861,160
-61,640
-7% -$1.49M 1.58% 27
2020
Q3 		$15.8M Buy
+922,800
New +$20.6M 1.36% 30
2020
Q2 		– Sell
-261,213
Closed -$3.63M – 195
2020
Q1 		$3.63M Buy
+261,213
New +$3.25M 0.7% 54

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Sectoral Asset Management's RCUS Position: Q2 2026 in Review

Sectoral Asset Management increased its Arcus Biosciences (RCUS) stake by 146% in Q2 2026, buying an estimated $1.63M and bringing the position to 110,870 shares worth $3.42M. The position accounts for 2.39% of the portfolio, ranked #10.

Sectoral Asset Management first reported a position in RCUS in Q1 2020 and has held it in 25 quarters since. The position peaked at $25.8M in Q3 2021. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Sectoral Asset Management held 110,870 shares of Arcus Biosciences worth $3.42M as of Q2 2026.
  • Sectoral Asset Management bought 65,800 Arcus Biosciences shares in Q2 2026, an estimated $1.63M.
  • Arcus Biosciences made up 2.39% of Sectoral Asset Management's portfolio in Q2 2026, its #10 holding.
  • Sectoral Asset Management first reported a position in Arcus Biosciences in Q1 2020 and has held it in 25 quarters since.
  • Sectoral Asset Management's Arcus Biosciences position peaked at $25.8M in Q3 2021.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.